We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+4.66%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$968M
AUM Growth
+$854M
Cap. Flow
+$792M
Cap. Flow %
81.87%
Top 10 Hldgs %
57.56%
Holding
371
New
110
Increased
49
Reduced
126
Closed
30

Top Buys

Rank Stock Value
1
EQM
EQM Midstream Partners, LP
EQM
+$80.7M
2
ETP
Energy Transfer Partners, L.P.
ETP
+$75.4M
3
MPLX icon
MPLX
MPLX
+$75.1M
4
MPC icon
Marathon Petroleum
MPC
+$60.6M
5
WMB icon
Williams Companies
WMB
+$40.5M

Top Sells

Rank Stock Value
1
VPU
Vanguard Utilities ETF
VPU
+$1.7M
2
VDE icon
Vanguard Energy ETF
VDE
+$1.28M
3
INDA icon
iShares MSCI India ETF
INDA
+$1.24M
4
FNCL icon
Fidelity MSCI Financials Index ETF
FNCL
+$1.04M
5
INCY icon
Incyte
INCY
+$637K

Sector Composition

Rank Sector Weight
1 Energy 68.15%
2 Healthcare 6.98%
3 Utilities 1.17%
4 Financials 0.09%
5 Technology 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BPMC
126
DELISTED
Blueprint Medicines
BPMC
$493K 0.05%
6,320
-4,520
-42% -$314K
CYTK icon
127
Cytokinetics
CYTK
$10.9B
$493K 0.05%
50,077
-35,803
-42% -$287K
QURE icon
128
uniQure
QURE
$2.63B
$489K 0.05%
13,451
-9,612
-42% -$358K
ACOR
129
DELISTED
Acorda Therapeutics
ACOR
$488K 0.05%
207
+14
+7% +$43.3K
KYNB
130
Kyntra Bio
KYNB
$28.5M
$487K 0.05%
321
-228
-42% -$351K
ITCI
131
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$483K 0.05%
22,258
-15,916
-42% -$333K
BOLD
132
DELISTED
Audentes Therapeutics, Inc
BOLD
$480K 0.05%
12,131
-8,679
-42% -$324K
ALBO
133
DELISTED
Albireo Pharma Inc
ALBO
$469K 0.05%
14,240
-10,448
-42% -$342K
CCXI
134
DELISTED
ChemoCentryx, Inc.
CCXI
$465K 0.05%
36,802
-27,027
-42% -$326K
ONC
135
BeOne Medicines Ltd
ONC
$33.8B
$456K 0.05%
2,649
-1,938
-42% -$326K
RDUS
136
DELISTED
Radius Health, Inc.
RDUS
$453K 0.05%
25,465
+1,716
+7% +$38.8K
KDNY
137
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$452K 0.05%
12,293
-8,787
-42% -$282K
MGNX icon
138
MacroGenics
MGNX
$254M
$451K 0.05%
21,029
-15,041
-42% -$321K
MRTX
139
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$451K 0.05%
9,575
-6,854
-42% -$382K
LOXO
140
DELISTED
Loxo Oncology, Inc
LOXO
$451K 0.05%
2,638
-1,897
-42% -$319K
XNCR icon
141
Xencor
XNCR
$1.47B
$449K 0.05%
11,509
-8,263
-42% -$337K
KPTI icon
142
Karyopharm Therapeutics
KPTI
$161M
$447K 0.05%
1,749
-1,250
-42% -$346K
KURA icon
143
Kura Oncology
KURA
$901M
$445K 0.05%
25,438
-18,195
-42% -$349K
XEL icon
144
Xcel Energy
XEL
$50.4B
$444K 0.05%
9,406
+8,822
+1,511% +$416K
STML
145
DELISTED
Stemline Therapeutics, Inc.
STML
$444K 0.05%
26,741
-19,109
-42% -$306K
DCPH
146
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$442K 0.05%
11,418
-8,377
-42% -$310K
BHVN
147
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$437K 0.05%
11,625
-8,529
-42% -$314K
AIMT
148
DELISTED
Aimmune Therapeutics
AIMT
$434K 0.04%
15,893
-11,359
-42% -$321K
SGYP
149
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$433K 0.04%
254,541
-186,920
-42% -$335K
IMGN
150
DELISTED
Immunogen Inc
IMGN
$427K 0.04%
45,112
-32,253
-42% -$310K
4 5
6
7 8

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q3 2018 Portfolio in Review

As of Q3 2018, Virtus ETF Advisers held 371 positions worth $968M, up 755% from $113M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Virtus ETF Advisers deployed $792M of net new capital in Q3 2018, opening 110 new positions and adding to 49 existing holdings. Its largest new stake was EQM Midstream Partners, LP: 1,479,454 shares worth $78.1M.

By sector, the portfolio is most concentrated in Energy at 68% of assets, up from 0.33% a quarter earlier, followed by Healthcare and Utilities.

On the sell side, the largest reduction was Vanguard Utilities ETF, an estimated $1.7M trimmed.

  • Virtus ETF Advisers's largest Q3 2018 buy was EQM Midstream Partners, LP: 1,479,454 shares worth $78.1M.
  • Virtus ETF Advisers added most to Marathon Petroleum in Q3 2018, an estimated $60.6M increase.
  • Virtus ETF Advisers's biggest Q3 2018 reduction was Vanguard Utilities ETF, cutting an estimated $1.7M.
  • Virtus ETF Advisers fully exited iShares MSCI India ETF in Q3 2018, selling an estimated $1.24M.
  • Virtus ETF Advisers's ten largest holdings make up 58% of its $968M portfolio in Q3 2018.
  • Virtus ETF Advisers opened 110 new positions and closed 30 in Q3 2018.
  • Virtus ETF Advisers's portfolio value rose 755% quarter-over-quarter to $968M.

Based on Virtus ETF Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.